References
- Abdel-Fattah AFM, Matsumoto K, Watanabe H (2000): Antinociceptive effects of Nigeifia sativa oil and its major component, thymoquinone, in mice. Eur J Pharmac 400: 89–97.
- Aqel-Mahmood B (1993a): The calcium antagonistic effect of the volatile oil of Nigela sativa seeds. Dirasat Series B Pure and Applied Science 19: 119–133.
- Aqel-Mahmood B (1993b): Effects of Nigela sativa seeds on intestinal smooth muscle. Int J Pharmacog 31: 55–60.
- Blaustein MD (1979): The role of calcium in catecholamine release from adrenergic nerve terminal, In: Paton DM, ed., Release of Catecholamine from Adrenergic Neuron. Oxford Pergamon, pp. 39–58.
- Bolton TB (1979): Mechanism of action of transmitters and other substances on smooth muscle. Physiol Rev 59: 606–718.
- Boskabadi MH, Shahabi M (1997): Bronchodilatory and anti-cholinergic effects of Nigella sativa on isolated guinea pig tracheal chains. Iran J Med Sci 22: 127–133.
- El-Sayed NSE1-Din (1998): Some pharmacological studies of Nigella sativa. M. Sc thesis, Faculty of Pharmacy, Cairo University.
- Filippo D'Antuono L, Moretti A, Lovato AFS (2002): Seed yield, yield components, oil content and essential oil content and composition of Nigella sativa L. and Nigella damascena L. Indust Crops Prod 15: 59–69.
- Gilani AH, Aziz N, Khurram IM (2001): Bronchodilator, spas-molytic and calcium antagonist activities of Nigella sativa seeds (Kalonji): A traditional herbal product with multiple medicinal uses. J Pak Med Assoc 51: 115–120.
- Godfraind T, Miller R, Wibo M (1986): Calcium antagonism and calcium entry blockade. Pharmacol Rev 38: 321–416.
- Hassan M, El-Dakhakhny M (1992): Effect of some Nigella sativa constituents on chemical cardnogenesis in hamster cheek pouch. J Egypt Soci Pharmac Exp Ther 11: 675–677.
- Hay DW, Wadsworth RM (1982): Effects of some organic calcium antagonists and other procedures affecting the Ca' translocation on KC1-induced contractions in the rat vas deferens. Br J Pharmac 76: 103–113.
- Houghton PI, Zarka R, De las Heras B, Hoult RS (1995): Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61: 33–36.
- Hoyle CHV, Burnstock G (1991): ATP receptors and their phys-iological roles. In: Stone TW, ed., Adenosine in the Nervous System. London, Academic Press Ltd., pp. 43-76.
- Jansen PCM (1981): Spices, Condiments and Medicinal Plants in Ethiopia, their Taxonomy and Agricultural Significance. Center for Agricultural Publishing and Documentation, Addis Ababa, pp. 76–85.
- Khoyi MA, Westfall DP, Buxton ILO, Akhtar-Kahavari F, Rezaei E, Salaices M, Sanchez-Garcia P (1988): Norepinephrine and potassium induced calcium translocation in rat vas deferens. J Pharmac Exp Ther 246: 917–923.
- Lipscombe D, Kongsamut S, Tsein RW (1989): Alpha-adrenergic inhibition of sympathetic neurotransmitter release-mediated by modulation of N-type calcium channel gating. Nature 340: 639–642.
- Mahfouz M, Abdel-Meguid R, El-Dakhakimy M (1960): Effectiveness of "Nigella" in asthma. Alexandria Med J 6: 543–547.
- Orallo F, Salaices M, Alonso MJ, Mann J, Sanchez-Garcia P (1992): Effects of several calcium channels modulators on the [3H]noradrenaline release and 'Ca influx in the rat vas deferens. Gen Pharmacol 32: 257–262.
- Riaz M, Syed M, Chaudhary FM (1996): Chemistry of the medicinal plants of the genus Nigella. Hamdard Medicus 39: 40–45.
- Siddiqui AA, Sharma PKR (1996): Clinical importance of Nigella sativa L. A review. Hamdard Medicus 39: 38–42.
- Spedding M, Paoletti R (1992): Classification of calcium chan-nels and the sites of action of drugs modifying channel function. Pharmacol Rev 44: 363–376.
- Triggle CR, Swamy V, Triggle JJ (1979): Calcium antagonists and contractile responses in rat vas deferens and guinea pig ileal muscle. Can J Physiol Pharmacol 57: 804–818.
- Tsein RW, Lipscombe D, Madison DV, Bley KR, Fox AP (1988): Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci 11: 431–437.
- Worthen DR, Ghosheh OA, Crooks PA (1998): The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer Res 18: 1527–1532.